Novartis AG
METHODS FOR TREATING HEMATOLOGIC CANCERS
Last updated:
Abstract:
The present invention relates to methods of treating hematologic cancers using a combination of inhibitors of PD-1 or PD-L1 and TIM-3, LAG-3 or CTLA4.
Status:
Application
Type:
Utility
Filling date:
23 Dec 2019
Issue date:
3 Dec 2020